Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:50 PM
Ignite Modification Date:
2025-12-24 @ 11:50 PM
NCT ID:
NCT01923051
Eligibility Criteria:
Inclusion Criteria:
* Post-bronchodilator FEV1/VC \< LLN and post-bronchodilator FEV1 ≤ 60% of the predicted value (VC - Vital Capacity, LLN - Lower Limit of Normal)
* Definite clinical diagnosis of COPD (can be overlaps: COPD + asthma / COPD + bronchiectasis)
* Stable course of COPD (≥ 8 weeks free of acute exacerbations and/or free of any acute conditions)
* Informed consent
Exclusion Criteria:
* "Pure" bronchial asthma without COPD
* "Pure" bronchiectasis without COPD
* Cystic fibrosis
* End-stage of COPD
* Non-curable malignancy
* Total non-compliance
* Immobility
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01923051
Study Brief:
Protocol Section:
NCT01923051